Syntax Bio reported research in Science Advances on its Cellgorithm platform, a CRISPR‑based system that programs gene activity in human stem cells to accelerate and standardize differentiation. The company claims the technology reduces processes that typically take months to weeks, offering a route to scale stem‑cell workflows for cell‑therapy and discovery programs. The paper provides mechanistic data on controllable gene regulation and positions programmable CRISPR circuits as an alternative to variable manual differentiation methods. Source: Science Advances publication and company materials.